Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 3,332 shares at $106.20 ($354K) on 2018-04-02, disclosed to the SEC on 2018-04-04.
Open-market sale of $354k MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.20 | 1,666 | $177K | 50.0% |
| 2 | $106.20 | 1,666 | $177K | 50.0% |
| Total | $106.20 avg | 3,332 | $354K | 100% |
| Filing → |
| MGLN | SELL | 2020-11-12 | $979K | — | Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |